Role of anti-pseudomonal antibiotics in the emergence ofStenotrophomonas maltophilia in cystic fibrosis patients
- 1 May 1996
- journal article
- clinical trial
- Published by Springer Science and Business Media LLC in European Journal of Clinical Microbiology & Infectious Diseases
- Vol. 15 (5), 402-405
- https://doi.org/10.1007/bf01690098
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Use of Antibiotics in Cystic FibrosisPublished by S. Karger AG ,2015
- Stenotrophomonas maltophilia in cystic fibrosis patientsEuropean Journal of Clinical Microbiology & Infectious Diseases, 1995
- The emergence of epidemic, multiple-antibiotic-resistant Stenotrophomonas (Xanthomonas) maltophilia and Burkholderia (Pseudomonas) cepaciaJournal of Hospital Infection, 1995
- Early treatment of Pseudomonas aeruginosa colonization in cystic fibrosisActa Paediatrica, 1993
- Susceptibility of Xanthomonas maltophilia to six quinolones and study of outer membrane proteins in resistant mutants selected in vitroAntimicrobial Agents and Chemotherapy, 1992
- Controlled study of Pseudomonas cepacia and Pseudomonas maltophilia in cystic fibrosis.Archives of Disease in Childhood, 1992
- Prevention of chronic Pseudomonas aeruginosa colonisation in cystic fibrosis by early treatmentThe Lancet, 1991
- Nosocomial Infections Due to Xanthomonas maltophilia (Pseudomonas maltophilia) in Patients with CancerClinical Infectious Diseases, 1990
- Use of antibiotics in cystic fibrosis. The Danish approach.1989
- NEBULISED COLOMYCIN FOR EARLY PSEUDOMONAS COLONISATION IN CYSTIC FIBROSISThe Lancet, 1985